Chicago Partners Investment Group LLC Buys 527 Shares of Colgate-Palmolive (NYSE:CL)

Chicago Partners Investment Group LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 10.0% during the third quarter, Holdings Channel.com reports. The institutional investor owned 5,809 shares of the company’s stock after purchasing an additional 527 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in Colgate-Palmolive were worth $575,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CL. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth $25,000. Continuum Advisory LLC increased its holdings in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after buying an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth $42,000. Gradient Investments LLC grew its holdings in shares of Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after purchasing an additional 400 shares during the last quarter. Finally, Financial Connections Group Inc. bought a new position in shares of Colgate-Palmolive during the 2nd quarter valued at $68,000. Institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CL. Morgan Stanley increased their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Piper Sandler began coverage on shares of Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Citigroup increased their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, UBS Group increased their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $105.11.

Colgate-Palmolive Trading Up 0.3 %

NYSE:CL opened at $93.61 on Tuesday. The company has a 50-day moving average price of $102.03 and a 200-day moving average price of $98.40. Colgate-Palmolive has a 12 month low of $74.67 and a 12 month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.28 and a debt-to-equity ratio of 9.46. The stock has a market cap of $76.48 billion, a price-to-earnings ratio of 26.82, a P/E/G ratio of 3.35 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.